Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

27.05USD
9:00pm BST
Change (% chg)

$0.65 (+2.46%)
Prev Close
$26.40
Open
$26.33
Day's High
$27.47
Day's Low
$26.14
Volume
88,434
Avg. Vol
175,386
52-wk High
$35.55
52-wk Low
$21.67

About

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein... (more)

Overall

No Ratios Available.

Financials

  ALLO.OQ Industry Sector
P/E (TTM): -- 21.40 19.24
EPS (TTM): -- -- --
ROI: -- 1.71 0.44
ROE: -- 6.73 15.61

Earnings vs. Estimates